Sign Up
Stories
Bioengineering Human Vein Implants Innovatively
Share
AVITA Medical to Announce 2023 Financial...
Curiteva Appoints Medical Device Veteran
Diabetic Foot Ulcers Market Set for Grow...
Cellcolabs Revolutionizes Stem Cell Prod...
Regenerative Medicine Market's Growth Pr...
Stryker's Q1 2024 Success
Overview
API
Norwegian startup ClexBio collaborates with Swiss R&D center CSEM to develop human vein implants using a bioreactor, aiming to treat chronic venous insufficiency. CEO Armend Håti foresees bioengineered solutions for wider medical applications, enabled by the VivoSet platform for scalable tissue cultivation.
Ask a question
How might the development of bioengineered vein implants impact traditional surgical procedures?
In what ways could this advancement in bioengineering influence the future of organ transplants?
What regulatory challenges could arise with the use of bioengineered tissues in medical treatments?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage